LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) announced a quarterly dividend on Tuesday, October 27th. Investors of record on Thursday, November 19th will be paid a dividend of $0.25 per share by the medical instruments supplier on Thursday, December 3rd. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend is Thursday, November 19th.
LeMaitre Vascular has increased its dividend by an average of 0.2% per year over the last three years and has raised its dividend annually for the last 14 consecutive years. LeMaitre Vascular has a payout ratio of 42.0% indicating that its dividend is sufficiently covered by earnings. Research analysts expect LeMaitre Vascular to earn $3.15 per share next year, which means the company should continue to be able to cover its $1.00 annual dividend with an expected future payout ratio of 31.7%.
LeMaitre Vascular Price Performance
Shares of LMAT stock opened at $77.01 on Tuesday. The firm has a market capitalization of $1.76 billion, a price-to-earnings ratio of 28.24, a price-to-earnings-growth ratio of 2.29 and a beta of 0.51. LeMaitre Vascular has a 12-month low of $76.60 and a 12-month high of $118.01. The company has a quick ratio of 12.54, a current ratio of 14.60 and a debt-to-equity ratio of 0.39. The firm has a fifty day moving average of $81.24 and a 200-day moving average of $93.91.
LeMaitre Vascular Company Profile
LeMaitre Vascular develops, manufactures and markets medical devices used primarily in the treatment of vascular disease. Its products support procedures performed by vascular surgeons and include vascular grafts, embolectomy catheters, carotid shunts, valvulotomes and other instruments used in vascular surgery. Founded in 1983 by vascular surgeon George LeMaitre, the company is headquartered in Burlington, Massachusetts. Its products are sold to hospitals and medical professionals around the world through a combination of direct sales and distributors.
Further Reading
- Five stocks we like better than LeMaitre Vascular
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.
